{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:15Z","timestamp":1791478335849,"version":"4.3.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05540-0","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:10:50Z","timestamp":1791429050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond diagnosing acute kidney injury: defining what we need from kidney biomarkers"],"prefix":"10.1038","author":[{"given":"Akash","family":"Deep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"5540_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1611391","volume":"376","author":"A Kaddourah","year":"2017","unstructured":"Kaddourah, A., Basu, R. K., Bagshaw, S. M. & Goldstein, S. L.for the AWARE Investigators Epidemiology of acute kidney injury in critically ill children and young adults. N. Engl. J. Med. 376, 11\u201320 (2017).","journal-title":"N. Engl. J. Med."},{"key":"5540_CR2","doi-asserted-by":"publisher","first-page":"e2019209","DOI":"10.1001\/jamanetworkopen.2020.19209","volume":"3","author":"M Ostermann","year":"2020","unstructured":"Ostermann, M. et al. Recommendations on acute kidney injury biomarkers from the Acute Disease Quality Initiative Consensus Conference: a consensus statement. JAMA Netw. Open 3, e2019209 (2020).","journal-title":"JAMA Netw. Open"},{"key":"5540_CR3","doi-asserted-by":"crossref","unstructured":"Feinauer, M. J., Fichtner, A. & Westhoff, J. H. TIMP-2 and IGFBP7 for the differentiation of functional and intrinsic pediatric acute kidney injury. Pediatr. Res. (accepted for publication, 2026).","DOI":"10.1038\/s41390-026-05405-6"},{"key":"5540_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/cc12503","volume":"17","author":"K Kashani","year":"2013","unstructured":"Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care 17, R25 (2013).","journal-title":"Crit. Care"},{"key":"5540_CR5","doi-asserted-by":"publisher","first-page":"e0143628","DOI":"10.1371\/journal.pone.0143628","volume":"10","author":"JH Westhoff","year":"2015","unstructured":"Westhoff, J. H. et al. Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) \u2022 insulin-like growth factor-binding protein 7 (IGFBP7) predicts adverse outcome in pediatric acute kidney injury. PLoS ONE 10, e0143628 (2015).","journal-title":"PLoS ONE"},{"key":"5540_CR6","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00467-016-3418-1","volume":"31","author":"JH Westhoff","year":"2016","unstructured":"Westhoff, J. H. et al. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury. Pediatr. Nephrol. 31, 2353\u20132363 (2016).","journal-title":"Pediatr. Nephrol."},{"key":"5540_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00467-023-06133-3","volume":"39","author":"DY Fuhrman","year":"2024","unstructured":"Fuhrman, D. Y. et al. A proposed framework for advancing acute kidney injury risk stratification and diagnosis in children: a report from the 26th Acute Disease Quality Initiative (ADQI) conference. Pediatr. Nephrol. 39, 929\u2013939 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"5540_CR8","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41390-022-02233-2","volume":"93","author":"NL Stanski","year":"2023","unstructured":"Stanski, N. L., Krallman, K. A., Chima, R. S. & Goldstein, S. L. A risk-stratified assessment of biomarker-based acute kidney injury phenotypes in children. Pediatr. Res. 93, 1354\u20131360 (2023).","journal-title":"Pediatr. Res."},{"key":"5540_CR9","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1007\/s00467-025-06920-0","volume":"40","author":"WF Hui","year":"2025","unstructured":"Hui, W. F. et al. The use of urinary biomarkers as prognostic tools: predicting kidney outcomes in pediatric acute kidney injury. Pediatr. Nephrol. 40, 3815\u20133823 (2025).","journal-title":"Pediatr. Nephrol."},{"key":"5540_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s44253-025-00086-1","volume":"3","author":"NL Stanski","year":"2025","unstructured":"Stanski, N. L., Oh, J. & Basu, R. K. The promise of biomarkers: precision medicine will pave a roadmap for pediatric acute kidney injury management in critically ill children. Intensive Care Med. Paediatr. Neonatal 3, 35 (2025).","journal-title":"Intensive Care Med. Paediatr. Neonatal"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05540-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05540-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05540-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:01Z","timestamp":1791475381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05540-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":10,"alternative-id":["5540"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05540-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"30 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.D. is an Associate Editor of Pediatric Research. He is President-Elect of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC) and Chair of the ESPNIC Working Group for Liver Failure. He is a consultant for BioPorto. No other competing interests are declared.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}